Attach to Form 990 or Form 990-EZ.
Go to
www.irs.gov/Form990 for instructions and the latest information.
| (i) Name of supported organization | (ii) EIN | (iii) Type of organization (described on lines 1- 10 above (see instructions)) | (iv) Is the organization listed in your governing document? | (v) Amount of monetary support (see instructions) | (vi) Amount of other support (see instructions) | |
|---|---|---|---|---|---|---|
| Yes | No | |||||
|
Total |
||||||
Calendar year
(or fiscal year beginning in)
![]() |
(a) 2017 | (b) 2018 | (c) 2019 | (d) 2020 | (e) 2021 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grant.") .. | ||||||
| 2 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf.... | ||||||
| 3 | The value of services or facilities furnished by a governmental unit to the organization without charge.. | ||||||
| 4 | Total. Add lines 1 through 3 | ||||||
| 5 | The portion of total contributions by each person (other than a governmental unit or publicly supported organization) included on line 1 that exceeds 2% of the amount shown on line 11, column (f) .. | ||||||
| 6 | Public support. Subtract line 5 from line 4. | ||||||
Calendar year
(or fiscal year beginning in)
![]() |
(a) 2017 | (b) 2018 | (c) 2019 | (d) 2020 | (e) 2021 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 7 | Amounts from line 4.. | ||||||
| 8 | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources... | ||||||
| 9 | Net income from unrelated business activities, whether or not the business is regularly carried on.. | ||||||
| 10 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.).. | ||||||
| 11 | Total support. Add lines 7 through 10 | ||||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2017 | (b) 2018 | (c) 2019 | (d) 2020 | (e) 2021 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") . | 36,500 | 29,860 | 6,200 | 72,560 | ||
| 2 | Gross receipts from admissions, merchandise sold or services performed, or facilities furnished in any activity that is related to the organization's tax-exempt purpose | 89,834 | 87,158 | 12,548 | 91,319 | 280,859 | |
| 3 | Gross receipts from activities that are not an unrelated trade or business under section 513 ..... | ||||||
| 4 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf... | ||||||
| 5 | The value of services or facilities furnished by a governmental unit to the organization without charge | ||||||
| 6 | Total. Add lines 1 through 5 | 126,334 | 117,018 | 18,748 | 91,319 | 353,419 | |
| 7a | Amounts included on lines 1, 2, and 3 received from disqualified persons | ||||||
| b | Amounts included on lines 2 and 3 received from other than disqualified persons that exceed the greater of $5,000 or 1% of the amount on line 13 for the year. | ||||||
| c | Add lines 7a and 7b.. | ||||||
| 8 | Public support. (Subtract line 7c from line 6.) | 353,419 | |||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2017 | (b) 2018 | (c) 2019 | (d) 2020 | (e) 2021 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 9 | Amounts from line 6... | 126,334 | 117,018 | 18,748 | 91,319 | 353,419 | |
| 10a | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources.. | 135 | 401 | 230 | 37 | 803 | |
| b | Unrelated business taxable income (less section 511 taxes) from businesses acquired after June 30, 1975. | ||||||
| c | Add lines 10a and 10b. | 135 | 401 | 230 | 37 | 803 | |
| 11 | Net income from unrelated business activities not included on line 10b, whether or not the business is regularly carried on. | ||||||
| 12 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.) .. | ||||||
| 13 | Total support. (Add lines 9, 10c, 11, and 12.).. | 126,469 | 117,419 | 18,978 | 91,356 | 354,222 | |
| Section A - Adjusted Net Income | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Net short-term capital gain | 1 | ||||
| 2 | Recoveries of prior-year distributions | 2 | ||||
| 3 | Other gross income (see instructions) | 3 | ||||
| 4 | Add lines 1 through 3 | 4 | ||||
| 5 | Depreciation and depletion | 5 | ||||
| 6 | Portion of operating expenses paid or incurred for production or collection of gross income or for management, conservation, or maintenance of property held for production of income (see instructions) | 6 | ||||
| 7 | Other expenses (see instructions) | 7 | ||||
| 8 | Adjusted Net Income (subtract lines 5, 6 and 7 from line 4) | 8 | ||||
| Section B - Minimum Asset Amount | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Aggregate fair market value of all non-exempt-use assets (see instructions for short tax year or assets held for part of year): | 1 | ||||
| a | Average monthly value of securities | 1a | ||||
| b | Average monthly cash balances | 1b | ||||
| c | Fair market value of other non-exempt-use assets | 1c | ||||
| d | Total (add lines 1a, 1b, and 1c) | 1d | ||||
| e |
Discount claimed for blockage or other factors (explain in detail in Part VI): |
|||||
| 2 | Acquisition indebtedness applicable to non-exempt use assets | 2 | ||||
| 3 | Subtract line 2 from line 1d | 3 | ||||
| 4 | Cash deemed held for exempt use. Enter 0.015 of line 3 (for greater amount, see instructions). | 4 | ||||
| 5 | Net value of non-exempt-use assets (subtract line 4 from line 3) | 5 | ||||
| 6 | Multiply line 5 by 0.035 | 6 | ||||
| 7 | Recoveries of prior-year distributions | 7 | ||||
| 8 | Minimum Asset Amount (add line 7 to line 6) | 8 | ||||
| Section C - Distributable Amount | Current Year | |||||
| 1 | Adjusted net income for prior year (from Section A, line 8, Column A) | 1 | ||||
| 2 | Enter 85% of line 1 | 2 | ||||
| 3 | Minimum asset amount for prior year (from Section B, line 8, Column A) | 3 | ||||
| 4 | Enter greater of line 2 or line 3 | 4 | ||||
| 5 | Income tax imposed in prior year | 5 | ||||
| 6 | Distributable Amount. Subtract line 5 from line 4, unless subject to emergency temporary reduction (see instructions) | 6 | ||||
| Section D - Distributions | Current Year | |
|---|---|---|
| 1 Amounts paid to supported organizations to accomplish exempt purposes | 1 | |
|
2
Amounts paid to perform activity that directly furthers exempt purposes of supported organizations, in excess of income from activity |
2 | |
| 3 Administrative expenses paid to accomplish exempt purposes of supported organizations | 3 | |
| 4 Amounts paid to acquire exempt-use assets | 4 | |
| 5 Qualified set-aside amounts (prior IRS approval required - provide details in Part VI) | 5 | |
| 6 Other distributions (describe in Part VI). See instructions | 6 | |
| 7Total annual distributions. Add lines 1 through 6. | 7 | |
|
8
Distributions to attentive supported organizations to which the organization is responsive (provide details in Part VI). See instructions |
8 | |
| 9 Distributable amount for 2021 from Section C, line 6 | 9 | |
| 10 Line 8 amount divided by Line 9 amount | 10 | |
| Section E - Distribution Allocations (see instructions) |
(i) Excess Distributions |
(ii) Underdistributions Pre-2021 |
(iii) Distributable Amount for 2021 |
|
|---|---|---|---|---|
| 1 Distributable amount for 2021 from Section C, line 6 | ||||
|
2
Underdistributions, if any, for years prior to 2021 (reasonable cause required-- explain in Part VI). See instructions. |
||||
| 3 Excess distributions carryover, if any, to 2021: | ||||
| a From 2016....... | ||||
| b From 2017....... | ||||
| c From 2018....... | ||||
| d From 2019....... | ||||
| e From 2020....... | ||||
| fTotal of lines 3a through e | ||||
| g Applied to underdistributions of prior years | ||||
| h Applied to 2021 distributable amount | ||||
|
i
Carryover from 2016 not applied (see instructions) |
||||
| j Remainder. Subtract lines 3g, 3h, and 3i from line 3f. | ||||
| 4Distributions for 2021 from Section D, line 7: | ||||
| $ | ||||
| a Applied to underdistributions of prior years | ||||
| b Applied to 2021 distributable amount | ||||
| c Remainder. Subtract lines 4a and 4b from line 4. | ||||
|
5
Remaining underdistributions for years prior to 2021, if any. Subtract lines 3g and 4a from line 2. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
6
Remaining underdistributions for 2021. Subtract lines 3h and 4b from line 1. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
7 Excess distributions carryover to 2022. Add lines 3j and 4c. |
||||
| 8 Breakdown of line 7: | ||||
| a Excess from 2017..... | ||||
| b Excess from 2018..... | ||||
| c Excess from 2019..... | ||||
| d Excess from 2020..... | ||||
| e Excess from 2021..... | ||||
| Facts And Circumstances Test |
|---|
| Return Reference | Explanation |
|---|
| Software ID: | |
| Software Version: |
Attach to Form 990 or 990-EZ.
Go to www.irs.gov/Form990 for the latest information.
| Return Reference | Explanation |
|---|---|
| FORM 990-EZ, PART I, LINE 8 | MISCELLANEOUS 2,198 TOTAL 2,198 |
| FORM 990-EZ, PART I, LINE 16 | EXPENSES ADVERTISING 602 OFFICE EXPENSE 1,310 TRAVEL 2,170 CONFERENCE BAGS 1,622 FACILITY EXPENSE 18,836 FOOD & BEVERAGE 25,538 LICENSES AND FEES 687 GIFTS 315 TOTAL 51,080 |
| FORM 990-EZ, PART III | THE SC HIV, STD AND VIRAL HEPATITIS CONFERENCE IS DESIGNED TO PROVIDE OPPORTUNITIES FOR PROFESSIONALS AND COMMUNITY MEMBERS TO ENGAGE IN DIALOGUE AND SHARE PAST SUCCESSES, DISCUSS CURRENT BEST PRACTICES AND INTERVENTIONS, COMMON CONCERNS, AS WELL AS ADDRESS EMERGING ISSUES AND TRENDS. IN RESPONSE TO THE OVERLAPPING EPIDEMICS OF HIV, STDS, AND VIRAL HEPATITIS, IT IS ESSENTIAL TO BUILD ON SUCCESSFUL PREVENTION, TREATMENT AND CARE STRATEGIES. THE SOUTH CAROLINA HIV, STD AND VIRAL HEPATITIS CONFERENCE PROVIDES AN ANNUAL FORUM TO SHARE BEST PRACTICES, COMMUNITY NETWORKING, RESOURCE BUILDING AND EDUCATION TOWARDS ENDING THE EPIDEMICS. THE OBJECTIVES FOR OUR ANNUAL EDUCATIONAL EVENT ARE TO INCREASE PARTICIPANT KNOWLEDGE OF: THE CURRENT STATUS OF MAJOR STDS/STIS AFFECTING SOUTH CAROLINIANS AS A PUBLIC HEALTH NEED FACTORS INFLUENCING STD-AFFECTED COMMUNITY BEHAVIORS, INCLUDING MODIFIABLE AND NON-MODIFIABLE SEXUAL AND HEALTH BEHAVIORS CURRENT LABORATORY PROCEDURES, LAWS, CLINICAL MANAGEMENT, AND IMPLICATIONS FOR PRACTICE IN STD CONTROL PROGRESSIVE COMMUNITY BASED AND STATE ORGANIZATIONS WORKING IN INTERDISCIPLINARY TEAMS, UNITED IN THE FIGHT AGAINST THE STIGMA, SPREAD OF, AND DISEASE PROGRESSION OF HIV, STDS, AND VH DURING OUR ANNUAL EVENT, WE SHARE BEST PRACTICES, COMMUNITY NETWORKING, RESOURCE BUILDING AND WIDESPREAD EDUCATION - THEREBY, ENHANCING THE GROWTH AND PROGRESS OF HIV, STD AND VH PREVENTION, CARE, AND TREATMENT IN SOUTH CAROLINA. |
| FORM 990-EZ, PART III, LINE 28 | THE 2021 SOUTH CAROLINA HIV, STD AND VIRAL HEPATITIS CONFERENCE WAS HELD OCTOBER 20, 2021 THROUGH OCTOBER 21, 2021. THE SC HIV, STD AND VIRAL HEPATITIS CONFERENCE IS DESIGNED FOR NURSE PRACTITIONERS, PHYSICIAN ASSISTANTS, NURSES, OTHER CLINICIANS, HIV/STD/VIRAL HEPATITIS EDUCATORS, SOCIAL WORKERS, CASE MANAGERS, PUBLIC HEALTH PROFESSIONALS, PHARMACISTS, OTHER SERVICE PROVIDERS, TEACHERS, STUDENTS, PEOPLE LIVING WITH HIV/AIDS AND OTHER INTERESTED COMMUNITY MEMBERS. THE MISSION FOR THIS INTERDISCIPLINARY CONFERENCE IS TO PROVIDE OPPORTUNITIES FOR PROFESSIONALS AND COMMUNITY MEMBERS TO ENGAGE IN DIALOGUE AND SHARE PAST SUCCESSES, DISCUSS CURRENT PRACTICES AND INTERVENTIONS, AS WELL AS ADDRESS EMERGING ISSUES AND TRENDS. TOPICS COVERED AND SPEAKERS INCLUDED: SC MEDICAID REFORMS AND THE IMPACT ON HIV HEALTH OUTCOMES TONY BROWN, MPH; PREVENTION PLANNING AND EVALUATION COORDINATOR, STD/HIV & VIRAL HEPATITIS DIVISION, SOUTH CAROLINA DHDC AT THE COMPLETION OF THIS ACTIVITY, THE PARTICIPANT WILL BE ABLE TO: 1. IDENTIFY VIRAL SUPPRESSION TRENDS FOR PEOPLE LIVING WITH HIV (PLWH) USING MEDICAID 2. DESCRIBE RETENTION IN CARE TRENDS FOR PLWH USING MEDICAID 3. RECOGNIZE MORTALITY TRENDS FOR PLWH USING MEDICAID HIV UPDATE 2021 SHARON B. WEISSMAN, MD; PROFESSOR OF INTERNAL MEDICINE, PALMETTO HEALTH/UOFSC MEDICAL GROUP AT THE COMPLETION OF THIS ACTIVITY, THE PARTICIPANT WILL BE ABLE TO: 1. REVIEW CURRENT TREATMENT AND PREVENTION GUIDELINE RECOMMENDATIONS FOR HIV 2. REVIEW NEW MEDICATIONS FOR HIV 3. REVIEW TOP RESEARCH FINDINGS IN HIV HCV TREATMENT UPDATE 2021 DIVYA AHUJA, MD; ASSOCIATE PROFESSOR OF CLINICAL, PALMETTO HEALTH/UOFSC MEDICAL GROUP AT THE COMPLETION OF THIS ACTIVITY, THE PARTICIPANT WILL BE ABLE TO: 1. DISCUSS THE LATEST HEPATITIS C SCREENING AND TESTING RECOMMENDATIONS 2. REVIEW HEPATITIS C LAB INTERPRETATION 3. DISCUSS THE HEPATITIS C TREATMENT GUIDELINES INCLUDING THE SIMPLIFIED ALGORITHM COMPARISON OF HIV PREP-TO-NEED RATIOS BY LITERACY RATES AMONG SC COUNTIES KENRIC B. WARE, PHARMD, MBA, AAHIVP; ASSOCIATE PROFESSOR OF PHARMACY, SOUTH UNIVERSITY MIA TURNER, PHARMD CANDIDATE 2022, SOUTH UNIVERSITY AT THE COMPLETION OF THIS ACTIVITY, THE PARTICIPANT WILL BE ABLE TO: 1. EXPLAIN THE IMPORTANCE OF HIV PREP-TO-NEED RATIOS (PNRS) AND THE VARIABILITY IN HIV PNRS AMONG COUNTIES IN SOUTH CAROLINA 2. DISCUSS ASSOCIATIONS IDENTIFIED BETWEEN HIV PNRS AND LITERACY RATES AT THE COUNTY LEVEL IN SOUTH CAROLINA 3. ANALYZE STRATEGIES TO IMPROVE HIV PNRS AMONG UNDERREPRESENTED COUNTIES IN SOUTH CAROLINA HIT ME WITH YOUR BEST SHOT: CABOTEGRAVIR/RILPIVIRINE LONG-ACTING INJECTABLE MORGAN PIZZUTI, PHARMD AND VIVIAN TSAI, PHARMD; PGY2 INFECTIOUS DISEASES PHARMACY RESIDENTS, PRISMA HEALTH RICHLAND AT THE COMPLETION OF THIS ACTIVITY, THE PARTICIPANT WILL BE ABLE TO: 1. APPLY CURRENT RECOMMENDATIONS REGARDING CABOTEGRAVIR AND RILPIVIRINE LONG-ACTING INJECTABLE FOR THE TREATMENT OF HIV 2. SUMMARIZE THE EFFICACY AND SAFETY OF CABOTEGRAVIR AND RILPIVIRINE LONG- ACTING INJECTABLE FOR HIV TREATMENT 3. DESCRIBE THE WORKFLOW OF IMPLEMENTING CABOTEGRAVIR AND RILPIVIRINE LONG-ACTING INJECTABLE INTO REAL-WORLD PRACTICE NOVEL THERAPIES FOR HIV TREATMENT AND PREVENTION CAROLINE DERRICK, PHARMD; INFECTIOUS DISEASES CLINICAL PHARMACIST, UOFSC SCHOOL OF MEDICINE AT THE COMPLETION OF THIS ACTIVITY, THE PARTICIPANT WILL BE ABLE TO: 1. DESCRIBE EMERGING TREATMENT OPTIONS FOR HIV INFECTED INDIVIDUALS 2. APPLY BARRIERS TO USE OF THESE AGENTS IN CLINICAL PRACTICE TO A REAL PATIENT CASE 3. OUTLINE PREVENTION STRATEGIES ON THE HORIZON FOR HIV |
| Software ID: | |
| Software Version: |